BCRB 2018

19/09/2018

ARCON improves loco-regional control in anemic patients

ARCON

Accelerated RT

100

100

80

80

20%

60

60

40

40

normal Hb low Hb

normal Hb low Hb

20

20

p < 0.01

0

0

0

12

24

36

48

60

0

12

24

36

48

60

months

months

Kaanders ESTRO 2012

41

RT ± Carbogen & nicotinamide for bladder cancer

42

Hoskin P J et al. JCO 2010;28:4912-4918